Omeros (OMER) Work In Process (2015 - 2021)
Omeros (OMER) reported Work In Process of $65000.0 for Q3 2021, down 91.84% on a YoY basis from $797000.0 in Q3 2020, and down 71.74% sequentially from $230000.0 in Q2 2021.
Omeros (OMER) Work In Process (2015 - 2021) Analysis & Trends
Omeros (OMER) has 5 years of Work In Process data on file, last reported at $65000.0 in Q3 2021.
- For the quarter ending Q3 2021, Work In Process fell 91.84% year-over-year to $65000.0; the trailing twelve-month figure through Sep 2021 stood at $65000.0 (down 91.84% YoY), and the FY2020 full-year result was $462000.0, up 36.69% from the prior year.
- Work In Process eased to $65000.0 in Q3 2021, from $230000.0 in the prior quarter.
- In the past five years, Work In Process ranged from a high of $1.2 million in Q2 2020 to a low of $65000.0 in Q3 2021.
- A 3-year average of $474090.9 and a median of $394000.0 in 2020 frame the typical range for Work In Process.
- Across the five-year window, Work In Process surged 114.16% in 2020 and tumbled 91.84% in 2021, its largest moves.
- Tracing OMER's Work In Process over 3 years: stood at $338000.0 in 2019, then surged by 36.69% to $462000.0 in 2020, then plunged by 85.93% to $65000.0 in 2021.
- Business Quant data shows OMER's Work In Process at $65000.0 in Q3 2021, $230000.0 in Q2 2021, and $405000.0 in Q1 2021.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Omeros | 739.31 Mn | 739.31 Mn | 9.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | 65,000.00 |
| Jun 30, 2021 | 230,000.00 |
| Mar 31, 2021 | 405,000.00 |
| Dec 31, 2020 | 462,000.00 |
| Sep 30, 2020 | 797,000.00 |
| Jun 30, 2020 | 1.20 Mn |
| Mar 31, 2020 | 394,000.00 |
| Dec 31, 2019 | 338,000.00 |
| Sep 30, 2019 | 379,000.00 |
| Jun 30, 2019 | 558,000.00 |
| Mar 31, 2019 | 392,000.00 |
| Dec 31, 2016 | 854,000.00 |
| Dec 31, 2015 | 158,000.00 |